Literature DB >> 28980876

Cell division cycle 20 promotes cell proliferation and invasion and inhibits apoptosis in osteosarcoma cells.

Guanning Shang1, Xu Ma1, Gang Lv1.   

Abstract

Cdc20 (cell division cycle 20 homologue) has been reported to exhibit an oncogenic role in human tumorigenesis. However, the function of Cdc20 in osteosarcoma (OS) has not been investigated. In the current study, we aim to explore the role of Cdc20 in human OS cells. Multiple approaches were used to measure cell growth, apoptosis, cell cycle, migration and invasion in OS cells after depletion of Cdc20 or overexpression of Cdc20. We found that down-regulation of Cdc20 inhibited cell growth, induced apoptosis and triggered cell cycle arrest in OS cells. Moreover, Cdc20 down-regulation let to inhibition of cell migration and invasion in OS cells. Consistently, overexpression of Cdc20 in OS cells promoted cell growth, inhibited apoptosis, enhanced cell migration and invasion. Mechanistically, our Western blotting results showed that overexpression of Cdc20 reduced the expression of Bim and p21, whereas depletion of Cdc20 upregulated Bim and p21 levels in OS cells. Altogether, our findings demonstrated that Cdc20 exerts its oncogenic role partly due to regulation of Bim and p21 in OS cells, suggesting that targeting Cdc20 could be useful for the treatment of OS.

Entities:  

Keywords:  Cdc20; Osteosarcoma; apoptosis; cell growth; invasion; migration

Mesh:

Substances:

Year:  2017        PMID: 28980876      PMCID: PMC5815435          DOI: 10.1080/15384101.2017.1387700

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  44 in total

Review 1.  State of the APC/C: organization, function, and structure.

Authors:  Janel R McLean; Denis Chaix; Melanie D Ohi; Kathleen L Gould
Journal:  Crit Rev Biochem Mol Biol       Date:  2011-01-24       Impact factor: 8.250

2.  Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

Authors:  Paul A Meyers; Cindy L Schwartz; Mark Krailo; Eugenie S Kleinerman; Donna Betcher; Mark L Bernstein; Ernest Conrad; William Ferguson; Mark Gebhardt; Allen M Goorin; Michael B Harris; John Healey; Andrew Huvos; Michael Link; Joseph Montebello; Helen Nadel; Michael Nieder; Judith Sato; Gene Siegal; Michael Weiner; Robert Wells; Lester Wold; Richard Womer; Holcombe Grier
Journal:  J Clin Oncol       Date:  2005-03-20       Impact factor: 44.544

3.  APC/C-mediated destruction of the centrosomal kinase Nek2A occurs in early mitosis and depends upon a cyclin A-type D-box.

Authors:  R S Hames; S L Wattam; H Yamano; R Bacchieri; A M Fry
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

4.  A CDC20-APC/SOX2 Signaling Axis Regulates Human Glioblastoma Stem-like Cells.

Authors:  Diane D Mao; Amit D Gujar; Tatenda Mahlokozera; Ishita Chen; Yanchun Pan; Jingqin Luo; Taylor Brost; Elizabeth A Thompson; Alice Turski; Eric C Leuthardt; Gavin P Dunn; Michael R Chicoine; Keith M Rich; Joshua L Dowling; Gregory J Zipfel; Ralph G Dacey; Samuel Achilefu; David D Tran; Hiroko Yano; Albert H Kim
Journal:  Cell Rep       Date:  2015-06-11       Impact factor: 9.423

5.  Pharmacologic inhibition of the anaphase-promoting complex induces a spindle checkpoint-dependent mitotic arrest in the absence of spindle damage.

Authors:  Xing Zeng; Frederic Sigoillot; Shantanu Gaur; Sungwoon Choi; Kathleen L Pfaff; Dong-Chan Oh; Nathaniel Hathaway; Nevena Dimova; Gregory D Cuny; Randall W King
Journal:  Cancer Cell       Date:  2010-10-19       Impact factor: 31.743

Review 6.  Cdc20: a potential novel therapeutic target for cancer treatment.

Authors:  Zhiwei Wang; Lixin Wan; Jiateng Zhong; Hiroyuki Inuzuka; Pengda Liu; Fazlul H Sarkar; Wenyi Wei
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

7.  An APC/C inhibitor stabilizes cyclin B1 by prematurely terminating ubiquitination.

Authors:  Xing Zeng; Randall W King
Journal:  Nat Chem Biol       Date:  2012-02-26       Impact factor: 15.040

8.  Curcumin suppresses cell growth and invasion and induces apoptosis by down-regulation of Skp2 pathway in glioma cells.

Authors:  Lixia Wang; Xiantao Ye; Xingming Cai; Jingna Su; Renqiang Ma; Xuyuan Yin; Xiuxia Zhou; Huabin Li; Zhiwei Wang
Journal:  Oncotarget       Date:  2015-07-20

9.  Cdc20 and securin overexpression predict short-term breast cancer survival.

Authors:  H Karra; H Repo; I Ahonen; E Löyttyniemi; R Pitkänen; M Lintunen; T Kuopio; M Söderström; P Kronqvist
Journal:  Br J Cancer       Date:  2014-05-22       Impact factor: 7.640

10.  CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer.

Authors:  Wen-jing Wu; Kai-shun Hu; De-shen Wang; Zhao-lei Zeng; Dong-sheng Zhang; Dong-liang Chen; Long Bai; Rui-hua Xu
Journal:  J Transl Med       Date:  2013-06-10       Impact factor: 5.531

View more
  15 in total

1.  Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis.

Authors:  Yuanyuan Wang; Zihao Zhou; Liang Chen; Yuzheng Li; Zengyuan Zhou; Xia Chu
Journal:  Mol Cell Biochem       Date:  2020-11-01       Impact factor: 3.396

2.  CDC20 and its downstream genes: potential prognosis factors of osteosarcoma.

Authors:  Man-Si Wu; Qing-Yu Ma; Dong-Dong Liu; Xiao-Juan Li; Li-Juan Deng; Nan Li; Jingnan Shen; Zhiqiang Zhao; Jia-Xu Chen
Journal:  Int J Clin Oncol       Date:  2019-07-05       Impact factor: 3.402

3.  The Prognostic Assessment of CDC20 in Patients with Renal Clear Cell Carcinoma and Its Relationship with Body Immunity.

Authors:  Jiaqi Shi; Yinhao Chen; Xiameng Gu; Xuerong Wang; Jing Liu; Xiaolan Chen
Journal:  Contrast Media Mol Imaging       Date:  2022-06-08       Impact factor: 3.009

4.  CDC20 is a novel biomarker for improved clinical predictions in epithelial ovarian cancer.

Authors:  Xiaoxue Xi; Tianyue Cao; Yonghong Qian; Huiling Wang; Songwen Ju; Youguo Chen; Ting Chen; Jian Yang; Biaoquan Liang; Shunyu Hou
Journal:  Am J Cancer Res       Date:  2022-07-15       Impact factor: 5.942

5.  Bioinformatics analysis reveals three key genes and four survival genes associated with youth-onset NSCLC.

Authors:  Xuan Han; Peng Ren; Shaohua Ma
Journal:  Open Med (Wars)       Date:  2022-07-06

6.  Diosgenin exerts its tumor suppressive function via inhibition of Cdc20 in osteosarcoma cells.

Authors:  Cheng Long; Juan Chen; Hua Zhou; Tao Jiang; Xiang Fang; Dong Hou; Ping Liu; Hong Duan
Journal:  Cell Cycle       Date:  2019-01-22       Impact factor: 4.534

7.  Inhibition of Cdc20 suppresses the metastasis in triple negative breast cancer (TNBC).

Authors:  Christine Song; Val J Lowe; SeungBaek Lee
Journal:  Breast Cancer       Date:  2021-04-03       Impact factor: 4.239

8.  NUSAP1 Accelerates Osteosarcoma Cell Proliferation and Cell Cycle Progression via Upregulating CDC20 and Cyclin A2.

Authors:  Haoran Wang; Zixiang Liu; Peng Wu; Hanqing Wang; Weiwei Ren
Journal:  Onco Targets Ther       Date:  2021-05-25       Impact factor: 4.147

9.  miR-16 integrates signal pathways in myofibroblasts: determinant of cell fate necessary for fibrosis resolution.

Authors:  Qin Pan; Can-Jie Guo; Qing-Yang Xu; Jin-Zhi Wang; Han Li; Chun-Hua Fang
Journal:  Cell Death Dis       Date:  2020-08-07       Impact factor: 8.469

10.  Identification of the Differentially Expressed Genes of Muscle Growth and Intramuscular Fat Metabolism in the Development Stage of Yellow Broilers.

Authors:  Dongfeng Li; Zaixu Pan; Kun Zhang; Minli Yu; Debing Yu; Yinglin Lu; Jiantao Wang; Jin Zhang; Kangning Zhang; Wenxing Du
Journal:  Genes (Basel)       Date:  2020-02-26       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.